251 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
5 Toxic Stocks to Dump or Play Short to Make Gains http://www.zacks.com/stock/news/252843/5-toxic-stocks-to-dump-or-play-short-to-make-gains?cid=CS-ZC-FT-252843 Mar 15, 2017 - Unreasonably high price of toxic stocks is only short-lived as the intrinsic value of these stocks is lower than the current bloated price.
Agenus (AGEN) Reports Narrower-than-Expected Loss in Q4 http://www.zacks.com/stock/news/252407/agenus-agen-reports-narrower-than-expected-loss-in-q4?cid=CS-ZC-FT-252407 Mar 10, 2017 - Agenus Inc. (AGEN) reported fourth-quarter 2016 loss of 30 cents per share (including non-cash expenses), narrower than the Zacks Consensus Estimate of a loss of 33 cents but wider than the year-ago loss of 18 cents.
How Incyte Stock Became a Bull Market Star for Biotech Investors http://www.zacks.com/stock/news/252365/how-incyte-stock-became-a-bull-market-star-for-biotech-investors?cid=CS-ZC-FT-252365 Mar 10, 2017 - Incyte (INCY) tops the list of stocks that enjoyed a stupendous run in the last 8 years.
A Trip to 8-Year Bull Run: What's Up, What's Down http://www.zacks.com/stock/news/252331/a-trip-to-8-year-bull-run-whats-up-whats-down?cid=CS-ZC-FT-252331 Mar 09, 2017 - While all the three major indices more than tripled scaling multiple highs in recent months, Nasdaq has won the maximum in the eight-year bull run.
Incyte Corporation (INCY) Presents At Cowen and Company 37th Annual Health Care Conference http://seekingalpha.com/article/4053781-incyte-corporation-incy-presents-cowen-company-37th-annual-health-care-conference?source=feed_sector_healthcare Mar 09, 2017 - The following slide deck was published by Incyte Corporation in conjunction with this event.
5 Top Stocks to Buy as Bull Market Turns Eight http://www.zacks.com/stock/news/252252/5-top-stocks-to-buy-as-bull-market-turns-eight?cid=CS-ZC-FT-252252 Mar 09, 2017 - We have selected 5 Buy-ranked stocks that have outperformed in the current bull market with room to run higher.
Mylan (MYL) Q2 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/227132/mylan-myl-q2-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-227132 Aug 05, 2016 - Mylan (MYL), which is set to report second-quarter 2016 results on Aug 9, delivered a positive earnings surprise of 1.33% last quarter.
Can TransDigm (TDG) Spring a Surprise in Q3 Earnings? http://www.zacks.com/stock/news/227022/can-transdigm-tdg-spring-a-surprise-in-q3-earnings?cid=CS-ZC-FT-227022 Aug 05, 2016 - TransDigm Group Incorporated (TDG) is set to report third-quarter fiscal 2016 results, after the closing bell on Aug 9.
BioDelivery (BDSI) Q2 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/226971/biodelivery-bdsi-q2-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-226971 Aug 05, 2016 - Last quarter, BioDelivery's loss was in-line with expectations. Let's see how things are shaping up for the second quarter of 2016.
Jazz (JAZZ) Q2 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/226965/jazz-jazz-q2-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-226965 Aug 05, 2016 - Our proven model does not conclusively show that Jazz (JAZZ) is likely to beat earnings estimates this quarter.

Pages: 1...1920212223242526

<<<Page 24>